We are live on ! Find out more
CDTX

Cidara Therapeutics

Delisted

CDTX was delisted on the 6th of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
BB
1
BB Biotech
Switzerland
$9.18M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$5.89M
IVM
3
InterWest Venture Management
California
$5.43M
FM
4
Frazier Management
Washington
$5.25M
PM
5
Prosight Management
Texas
$4.75M -$3.15M -23,076 -28%
AC
6
Aisling Capital
New York
$4.08M
Millennium Management
7
Millennium Management
New York
$2.36M -$26.6K -195 -0.7%
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.26M -$3.83K -28 -0.1%
OFM
9
Omega Fund Management
Massachusetts
$1.78M
BC
10
Broadfin Capital
New York
$1.5M -$3.29M -24,079 -56%
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$1.42M +$2.43M +17,800 New
RSCM
12
Rock Springs Capital Management
Maryland
$1.2M
Renaissance Technologies
13
Renaissance Technologies
New York
$1.05M +$563K +4,120 +46%
BlackRock
14
BlackRock
New York
$998K +$1.24M +9,059 +265%
GC
15
Guggenheim Capital
Illinois
$895K +$826K +6,044 +117%
TCM
16
Tekla Capital Management
Massachusetts
$635K -$872K -6,385 -45%
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$416K +$206K +1,507 +41%
Goldman Sachs
18
Goldman Sachs
New York
$409K +$698K +5,109 New
WFI
19
West Family Investments
California
$400K
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$387K -$6.01K -44 -0.9%
RJA
21
Raymond James & Associates
Florida
$384K +$485K +3,549 +284%
BCM
22
Bridgeway Capital Management
Texas
$376K
ACM
23
Alethea Capital Management
Washington
$312K +$175K +1,282 +49%
OAM
24
Oxford Asset Management
United Kingdom
$305K +$323K +2,363 +163%
JP Morgan Chase
25
JP Morgan Chase
New York
$277K +$220K +1,609 +87%